Local formation of angiotensin peptides with paracrine activity by adipocytes

Journal of Peptide Science

Volumn 15, Issue 11, 2009, Pages 767-776

  Weiland, Felix ^a   Verspohl, Eugen J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Angiotensin; IRAP assay; Peptide degradation

Indexed keywords

AMINOPEPTIDASE; ANGIOTENSIN; ANGIOTENSIN 4 RECEPTOR; ANGIOTENSIN [1-10]; ANGIOTENSIN [1-7]; ANGIOTENSIN [1-9]; ANGIOTENSIN [3-7]; ANGIOTENSIN II; ANGIOTENSIN II [1-8]; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN III [2-8]; ANGIOTENSIN RECEPTOR; INSULIN REGULATED AMINOPEPTIDASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CAPILLARY ELECTROPHORESIS; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ASSAY; INSULIN SENSITIVITY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN DEGRADATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEPARATION TECHNIQUE; SUPERNATANT;

3T3-L1 CELLS; ADIPOCYTES; ANGIOTENSINS; ANIMALS; ELECTROPHORESIS, CAPILLARY; MICE;

EID: 70449625770     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1174     Document Type: Article

References (43)

1. Karlsson C, Lindell K, Ottosson M, Sjostrom L, Carlsson B, Carlsson LM. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J. Clin. Endocrinol. Metab. 1998; 83: 3925-3929. (Pubitemid 28513574)
2. Sharma AM, Janke J, Gorzelniak K, Engeli S, Luft FC. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 2002; 40: 609-611. (Pubitemid 35278594)
3. Schling P, Loffler G. Cross talk between adipose tissue cells: impact on pathophysiology. News Physiol. Sci. 2002; 17: 99-104.
4. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 2002; 51: 1699-1707. (Pubitemid 34564280)
5. Saye JA, Ragsdale NV, Carey RM, Peach MJ. Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. Am. J. Physiol. 1993; 264: C1570-1576.
6. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, Egan GF, McKinley MJ, Rodger PD, Sinclair AJ, Wark JD, Weisinger HS, Jois M, Weisinger RS. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc. Natl. Acad. Sci. U.S.A. 2008; 105: 6531-6536. (Pubitemid 351754541)
7. Jayasooriya AP, Begg DP, Chen N, Mathai ML, Sinclair AJ, Wilkinson-Berka J, Wark JD, Weisinger HS, Weisinger RS. Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats. Prostaglandins Leukot. Essent. Fatty Acids 2008; 78: 67-72.
8. Weisinger HS, Begg DP, Egan GF, Jayasooriya AP, Lie F, Mathai ML, Sinclair AJ, Wark JD, Weisinger RS. Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats. Physiol. Behav. 2008; 93: 820-825.
9. Weisinger RS, Stanley TK, Begg DP, Weisinger HS, Spark KJ, Jois M. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiol. Behav. 2009; 98: 192-197.
10. Schling P, Schafer T. Human adipose tissue cells keep tight control on the angiotensin ii levels in their vicinity. J. Biol. Chem. 2002; 277: 48066-48075. (Pubitemid 35470753)
11. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Coexpression of renin-angiotensin system genes in human adipose tissue. J. Hypertens. 1999; 17: 555-560. (Pubitemid 29308566)
12. Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J. Hypertens. 2002; 20: 965-973. (Pubitemid 34913678)
13. Moro C, Klimcakova E, Lafontan M, Berlan M, Galitzky J. Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis. Br. J. Pharmacol. 2007; 152: 1102-1110. (Pubitemid 350166053)
14. Crandall DL, Herzlinger HE, Saunders BD, Armellino DC, Kral JG. Distribution of angiotensin II receptors in rat and human adipocytes. J. Lipid. Res. 1994; 35: 1378-1385. (Pubitemid 24251032)
15. Mallow H, Trindl A, Loffler G. Production of angiotensin II receptors type one (AT1) and type two (AT2) during the differentiation of 3T3-L1 preadipocytes. Horm.Metab. Res. 2000; 32: 500-503. (Pubitemid 32176077)
16. Schling P. Expression of angiotensin II receptors type 1 and type 2 in human preadipose cells during differentiation. Horm. Metab. Res. 2002; 34: 709-715. (Pubitemid 36398712)
17. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 2002; 51: 1699-1707. (Pubitemid 34564280)
18. Iwai M, Horiuchi M. Role of renin-angiotensin system in adipose tissue dysfunction. Hypertens. Res. 2009; 32: 425-427.
19. Iwai M, Tomono Y, Inaba S, Kanno H, Senba I, Mogi M, Horiuchi M. AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice. Am. J. Hypertens. 2009; 22: 784-791.
20. Mendes ACR, Ferreira AJ, Pinheiro SVB, Santos RAS. Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats. Regul.Pept. 2005; 125: 29-34. (Pubitemid 39593704)
21. Harding JW, Yoshida MS, Dilts RP, Woods TM, Wright JW. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat. J. Neurochem. 1986; 46: 1292-1297.
22. Abhold RH, Harding JW. Metabolism of angiotensin II and III by membrane-bound peptidases from rat brain. J. Pharmacol. Exp. Ther. 1988; 245: 171-177.
23. Kasicka V. Recent developments in CE and CEC of peptides. Electrophoresis 2008; 29: 179-206.
24. Oda RP, Clark R, Katzmann J, Landers JP. Capillary electrophoresis as a conical tool for the analysis of protein in serum and other body fluids. Electrophoresis 1997; 18: 1715-1723. (Pubitemid 27451825)
25. Freitag R, Hilbrig F. Theory and practical understanding of the migration behavior of proteins and peptides in CE and related techniques. Electrophoresis 2007; 28: 2125-2144. (Pubitemid 47065141)
26. Smith RD, Olivares JA, Nguyen NT, Udseth HR. Capillary zone electrophoresis - mass spectrometry using an electrospray ionization interface. Anal. Chem. 1988; 60: 436-441.
27. Olivares JA, Nguyen NT, Yonker CR, Smith RD. On-line mass spectrometric detection for capillary zone electrophoresis. Anal. Chem. 1987; 59: 1230-1232.
28. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FAO, Simpson RJ, Connolly LM Chai SY. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 2001; 276: 48623-48626. (Pubitemid 37370555)
29. Herbst JJ, Ross SA, Scott HM, Bobin SA, Morris NJ, Lienhard GE, Keller SR. Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes. Am. J. Physiol. Endocrinol. Metab. 1997; 272: E600.
30. Chai SY, Fernando MA, Peck G, Ye SY, Mendelsohn FAO, Jenkins TA, Albiston AL. The angiotensin IV/AT4 receptor. Cell.Mol. Life Sci. 2004; 61: 2728-2737.
31. Green H, Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974; 3: 127-133.
32. Lim BC, Sim MK. Determination of angiotensins by capillary electrophoresis. J. Chromatogr. B. Biomed. Appl. 1994; 655: 127-131.
33. Lacher NA, Garrison KE, Lunte SM. Separation and detection of angiotensin peptides by Cu(II) complexation and capillary electrophoresis with UV and electrochemical detection. Electrophoresis 2002; 23: 1577-1584. (Pubitemid 34727597)
34. Stragier B, Demaegdt H, Bundel DD, Smolders I, Sarre S, Vauguelin G, Ebinger G, Michotte Y, Vanderheyden P. Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat. Brain. Res. 2007; 1131: 97-105. (Pubitemid 46070177)
35. 125I]Ang IV binding and catalytic activity. Biochem. Pharmacol. 2004; 68: 885-892.
36. Tamura Y, Niinobe M, Arima T, Okuda H, Fujii S. Aminopeptidases and arylamidases in normal and cancer tissues in humans. Cancer. Res. 1975; 35: 1030-1034.
37. Handa RK. Metabolism alters the selectivity of angiotensin-(1-7) receptor ligands for angiotensin receptors. J.Am. Soc. Nephrol. 2000; 11: 1377-1386.
38. Plovsing RR, Wamberg C, Sandgaard NCF, Simonsen JA, Holstein-Rathlou NH, Hoilund-Carlsen PF, Bie P. Effects of truncated angiotensins in humans after double blockade of the rennin system. Am. J. Physiol. Regul. Integr.Comp. Physiol. 2003; 285: R981-991. (Pubitemid 37296347)
39. Wamberg C, Plovsing RR, Sandgaard NCF, Bie P. Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003; 285: R971-980.
40. Lew RA, Mustafa T, Ye S, McDowall SG, Chai SY, Albiston AL. Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J. Neurochem. 2003; 86: 344-350. (Pubitemid 36842433)
41. Wright JW, Stubley L, Pederson ES, Kramar EA, Hanesworth JM, Harding JW. Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. J. Neurosci. 1999; 19: 3952-3961. (Pubitemid 29222269)
42. Wright JW, Krebs LT, Stobb JW, Harding JW. The angiotensin IV system: functional implications. Front. Neuroendocrinol. 1995; 16: 23-52.
43. Weiland F, Verspohl EJ. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes. Horm. Metab. Res. 2008; 40: 760-766.